CaspofunginImmuneSafety Rating 8/10

Primary research areaInvasive candidiasis

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range70 mg IV loading then 50 mg daily
AdministrationIntravenous
Safety8/10 · FDA-approved (Cancidas)
NCAA D1Permitted

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Caspofungin

Mechanism of action

Echinocandin antifungal; inhibits beta-1,3-D-glucan synthase disrupting fungal cell wall integrity

Safety profile

Fever, elevated liver enzymes, GI effects, rash, phlebitis · Well-established echinocandin; rare hepatotoxicity; generally well-tolerated

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Caspofungin

Failed to fetch